Americann Inc. · OTC:ACAN
Americann — Investor Presentation (April 2018)
20 slides from Americann's investor presentation, Apr 24, 2018
Slide 1: Innovation for the Next Great Industry
INNOVATION FOR THE NEXT GREAT INDUSTRY
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation has been prepared by the company and includes information from other sources believed by management to be reliable. No representation or warranty, express or implied, is made as to the accuracy or completeness of any of the information set forth herein. T
Slide 3: About AmeriCann, Inc.
ABOUT AMERICANN, INC. PUBLICLY TRADED COMPANY | OTCQX: ACAN DESCRIPTION OF COMPANY AmeriCann is an Ag-Tech company that is designing, developing and will lease sustainable, state-of-the-art medical cannabis cultivation properties. The Company does not currently cultivate, process, distribute or sell
Slide 4: Stock Snapshot
STOCK SYMBOL (OTCQX) SHARES OUTSTANDING MARKET CAP @ $2.80 OTe The OTCQB® Venture Market is for Share Price 4/23/2018 AVG. DAILY VOLUME early-stage and developing U.S. and international companies. Companies must be current in their reporting and undergo an annual verification and management certific
Slide 5: Current Growth of Regulated Medical Cannabis
CURRENT GROWTH OF REGULATED MEDICAL CANNABIS STATES 29 states have approved rn egulations for dents NO SPECIFIC LAWS @ (LEGAL FOR MEDICAL USE Over 60% of e@ CONSIDERING LEGISLATION LEGAL FOR ADULT CONSUMPTION with medical cz medice 89% of US Voters support Medical Marijuana 64% of US Voters support
Slide 6: Interstate Commerce
Slide 7: Industry Growth
INDUSTRY GROWTH Estimated National Cannabis Sales* ja (ao $50 Billion a *Source:
Slide 8: National Cannabis Legalization Will Require $27 Billion of Infrastructure
NATIONAL CANNABIS LEGALIZATION WILL REQUIRE be. $27 BILLION OF INFRASTRUCTURE Inn $679 MILLION ! $382 MILLION $27 BILLION $2.1 BILLION | NATIONAL TOTAL jures from Colorado. Actual results may vary. AmeriCann &
Slide 9: Sustainability: Why Greenhouse?
SUSTAINABLITY WHY GREENHOUSE? Greenhouses OVERALL USE 25% FEWER UTILITY BILLS LIGHT BULBS ARE 75% LESS THAN INDOOR in green house for comparable warehouse. Lower carbon footprint. Warehouse construction costs an estimated $225 PER SQ FT TO BUILD VS. $125 per square footto build ultra efficient Green
Slide 10: Case Study: Massachusetts Market
CASE STUDY MASSACHUSETTS MARKET “Legal Marijuana Adult-Use Sales on track could be a $1.1 Billion @ for July 1, 2018 industry in Mass. by 2020" ~ Boston Globe, March 2016 47,000 Certified and Registered Patients that continues to expand toward 125,000 va y I DISPENSARIES @ APPLICANTS Cannabis Contro
Slide 11: The Problem
THE PROBLEM Massachusetts does not have enough cultivation infrastructure to support medical patients IMPACT OF LIMITED INFRASTRUCTURE HIGH PRICES ‘Square Feet (M) LIMITED_ SELECTION FOR PATIENTS LIMITED QUANTITIES FOR HIGH NEED PATIENTS LIMITED STOCK FOR DISPENSARIES MASSACHUSETTS MEDICAL CANNABIS
Slide 12: Million Square Feet of Ready and Approved Cultivation Infrastructure
1 MILLION square feet of ready-and approved cultivation and processing infrastructure Massachusetts Medical hopoal _Ipar ~Pase on Cannabis Center Sconritny 2a ee Agreement Engineering Sai se ¥ Storm Water Pssegorenl Report Mgmt Pian Architectural re Sorte! WaT sie < % = Design Sa ‘AmeriCann.co *vinf
Slide 13: Shovel Ready
Shovel Ready All studies, design, planning & approvals in place Preferred Partner ¥ Host Community for 1st Phase. Agreement in Place - BASK, Inc. - 15 Year Lease v¥90-Year -Tenantis 1 Ground Lease of limited - Commence approved RMDs. Oct.17%, 2016. ~ Dispensar = aipnies ¥ Ground Breaking from MMCC -
Slide 14: Sq. Ft. Facility
0 SQ. FT. FACILITY — a Pigining, Massachusetts Medical | laa approved the-adaifion Cannabis Center ) } , preen ceseeich \ and Development Center ) fo : “AmeriCann.co info@AmeriCann.co (303) 862-9000 ‘Stock Symbot ACAN AmeriCann
Slide 15: Product Development
PRODUCT DEVELOPMENT a > os Soran SOLANNA SOLANNA SOLANNA SOLANNA NEUTRACEUTICAL LINE OF INFUSED PRODUCTS: *LOTIONS AND BALMS *CAPSULES *SUBLINGUAL TINCTURES *ORAL DISOLVING FILM + TRANSDERMAL APPLICATIONS -OIL CARTRIDGES FOR VAPOR GROWTH OF INFUSED PRODUCTS INFUSED PRODUCTS INCREASED F % OF TOTAL SA
Slide 16: The People
THE PEOPLE EXPERIENCED MANAGEMENT TEAM & ADVISORS Insiders have invested over $5 Million in equity & debt to date MANAGEMENT & DIRECTORS TIM KEOGH President, CEO & Director BEN BARTON AmeriCann’s team CFO, Director, Founder hes aes BRIAN E. CORR, PHD experience from Dir. of Horticultural Science and
Slide 17: The People: Management Team Track Record
THE PEOPLE _ theamericann management team has a proven track record of success for real estate development, startup public company and capital markets experience and success. Tim Keogh - AmeriCann President and CEO Mr. Keogh is recognized as one of the leading experts in the medical cannabis industr
Slide 18: Investment Highlights
INVESTMENT HIGHLIGHTS MARKET DRIVERS & OPPORTUNITY Increased momentum towards the end of cannabis prohibition 29 states legalized for medical 8 States and Washington, D.C. legalized for recreational Highly fragmented industry with national leaders begining to emerge PEOPLE & RELATIONSHIPS Early indu
Slide 19: AmeriCann Corporate Information
AmeriCann CORPORATE INFORMATION OTCQB: ACAN If have questions about AmeriCann please contact Tim Keogh, CEO, at (303) 862-9000 or email timk@americann.co www.americann.co INVESTOR RELATIONS Hayden IR New York, NY 917.658.7878 ATTORNEYS Hart & Hart, LLC Denver, CO CannaLaw Group Seattle, WA/ Chicago,
Slide 20: Innovation for the Next Great Industry
INNOVATION FOR THE NEXT GREAT INDUSTRY info@AmeriCann.co (303) 862-9000